Leveraging data-driven patient and healthcare provider (HCP) insights, including social drivers of health (SDOH), is essential for life sciences companies to continuously improve patient engagement and commercial success. Mark Rodgers, AVP of Commercial Analytics at Inovalon, discusses how identifying treatment milestones, assessing HCP performance, and segmenting patient populations using SDOH data can drive targeted strategies that improve healthcare outcomes and market access
Related Posts
Accelerating Breakthroughs with Synthetic Clinical Trial Data
Mandis Beigi, Senior Director Afrah Shafquat, Senior Staff Data Scientist Jia Chen, PhD, Senior Director, Medidata AI Jacob Aptekar, Vice…
Obe-Cel Achieves High Response Rates, Durable Outcomes in r/r B-Cell Acute Lymphoblastic Leukemia
Credit: Arif Biswas | stock.adobe.com Obecabtagene autoleucel (obe-cel; Autolus Therapeutics)—a CD19 chimeric antigen receptor (CAR) T-cell therapy—produced high response rates…
Analyzing Industry’s Current Perceptions of Parallel-Group Cluster-Randomized Trials
Image Credit: © Andrii Yalanskyi – stock.adobe.com A recent study published by the National Library of Medicine aimed to evaluate…
